United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok) - anhydrous dextrose 13.6 g in 1000 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.15 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - potassium chloride; glucose monohydrate - solution for infusion - 0.3 + 5 percent weight/volume - solutions affecting the electrolyte balance; electrolytes with carbohydrates - blood substitutes and perfusion solutions; electrolytes with carbohydrates - prevention and treatment of potassium depletion and/or hypokalaemia in cases where supply of water and carbohydrates is required due to either restriction of the intake of fluids and electrolytes or depletion by normal routes.

Ireland - English - HPRA (Health Products Regulatory Authority)

fmc pharma ltd - glucosamine sulfate - film-coated tablet - 750 milligram(s) - other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

Ireland - English - HPRA (Health Products Regulatory Authority)

fmc pharma ltd - glucosamine sulfate - film-coated tablet - 1500 milligram(s) - other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

Ireland - English - HPRA (Health Products Regulatory Authority)

pharma nord aps - glucosamine - capsule, hard - 400 milligrams per capsule - other antiinflammatory and antirheumatic agents, non-steroids; glucosamine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharma nord aps - glucosamine sulfate potassium chloride 676 mg - eq. glucosamine 400 mg - capsule, hard - 400 mg - glucosamine sulfate potassium chloride - glucosamine

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - glucosamine hydrochloride, quantity: 750 mg - tablet, film coated - excipient ingredients: povidone; calcium phosphate; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3000; iron oxide black - temporary relief of the pain of arthritis. (or) temporary relief of arthritic pain. [warning s required] may help reduce joint inflammation associated with arthritis. may help reduce joint swelling associated with arthritis. may help increase joint mobility associated with arthritis. for the management of osteoarthritis leading to temporary relief from joint pain within 3-6 weeks. provides a concentrated dose of an essential building block, glucosamine, which is a naturally occuring amino sugar. supplementation with glucosamine helps to replenish the supply of this compound in the body and has been shown to have particular clinical benefits in people suffering from osteoarthritis. specially developed for the temporary relief of pain in people diagnosed with osteoarthritis.